Ownership Submission
FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Fung Eric T
 2. Date of Event Requiring Statement (Month/Day/Year)
06/19/2006		 3. Issuer Name and Ticker or Trading Symbol
CIPHERGEN BIOSYSTEMS INC [CIPH]
(Last)
(First)
(Middle)
C/O CIPHERGEN BIOSYSTEMS, INC., 6611 DUMBARTON CIRCLE		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
VP-Chief Science Officer
 5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

FREMONT, CA 94555		 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Common Stock Options   (1) 05/02/2010 Common Stock 4,300 $ 3.488 D  
Common Stock Options   (2) 06/06/2011 Common Stock 6,000 $ 6.38 D  
Common Stock Options   (3) 11/07/2011 Common Stock 5,000 $ 5.6 D  
Common Stock Options   (4) 06/05/2012 Common Stock 5,000 $ 4.53 D  
Common Stock Options   (5) 02/12/2013 Common Stock 15,000 $ 4.35 D  
Common Stock Options   (6) 06/04/2013 Common Stock 10,000 $ 9.6 D  
Common Stock Options   (7) 03/31/2014 Common Stock 20,000 $ 8.64 D  
Common Stock Options   (8) 06/02/2014 Common Stock 25,000 $ 7.47 D  
Common Stock Options   (9) 09/15/2014 Common Stock 10,000 $ 3.7 D  
Common Stock Options   (10) 04/05/2015 Common Stock 30,000 $ 1.8 D  
Common Stock Options   (11) 08/04/2015 Common Stock 20,000 $ 2.19 D  
Common Stock Options   (12) 12/19/2015 Common Stock 10,000 $ 0.9 D  
Common Stock Options   (13) 06/06/2016 Common Stock 75,000 $ 1.2 D  
Common Stock Options   (14) 04/25/2017 Common Stock 240,000 $ 1.47 D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Fung Eric T
C/O CIPHERGEN BIOSYSTEMS, INC.
6611 DUMBARTON CIRCLE
FREMONT, CA 94555		       VP-Chief Science Officer  

Signatures

/s/ Eric T. Fung 07/23/2007
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) This option became fully vested on May 1, 2005.
(2) This option became fully vested on December 20, 2005.
(3) This option became fully vested on December 20, 2005.
(4) This option became fully vested on December 20, 2005.
(5) This option became fully vested on December 20, 2005.
(6) This option became fully vested on December 20, 2005.
(7) This option became fully vested on December 20, 2005.
(8) This option became fully vested on December 20, 2005.
(9) This option vests in 60 consecutive equal monthly installments, beginning on September 16, 2004, provided the optionee continues to provide services to the Company.
(10) This option vests in 60 consecutive equal monthly installments, beginning on April 6, 2005, provided the optionee continues to provide services to the Company.
(11) This option vests in 24 consecutive equal monthly installments, beginning on August 5, 2005, provided the optionee continues to provide services to the Company.
(12) This option vests in 24 consecutive equal monthly installments, beginning on December 20, 2005, provided the optionee continues to provide services to the Company.
(13) This option vests in 48 consecutive equal monthly installments, beginning on June 7, 2006, provided the optionee continues to provide services to the Company.
(14) This option vests in 48 consecutive equal monthly installments, beginning on April 26, 2007, provided the optionee continues to provide services to the Company.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.